Acute kidney injury in villous cancer patients treated with vancomycin and tazobactam/piperacillin

In this report, we present a 37‐year‐old woman with villous cancer who developed AKI after co‐administration of VCM and TAZ/PIPC. Trough concentration of VCM reach a toxic level. Finally, she recovered on day 17.[Image: see text]

Detalles Bibliográficos
Autores principales: Nakatani, Kaori, Momo, Kenji, Mimura, Takashi, Yoshiizumi, Eri, Sasaki, Tadanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347319/
https://www.ncbi.nlm.nih.gov/pubmed/35937011
http://dx.doi.org/10.1002/ccr3.6081
_version_ 1784761837267451904
author Nakatani, Kaori
Momo, Kenji
Mimura, Takashi
Yoshiizumi, Eri
Sasaki, Tadanori
author_facet Nakatani, Kaori
Momo, Kenji
Mimura, Takashi
Yoshiizumi, Eri
Sasaki, Tadanori
author_sort Nakatani, Kaori
collection PubMed
description In this report, we present a 37‐year‐old woman with villous cancer who developed AKI after co‐administration of VCM and TAZ/PIPC. Trough concentration of VCM reach a toxic level. Finally, she recovered on day 17.[Image: see text]
format Online
Article
Text
id pubmed-9347319
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93473192022-08-05 Acute kidney injury in villous cancer patients treated with vancomycin and tazobactam/piperacillin Nakatani, Kaori Momo, Kenji Mimura, Takashi Yoshiizumi, Eri Sasaki, Tadanori Clin Case Rep Case Report In this report, we present a 37‐year‐old woman with villous cancer who developed AKI after co‐administration of VCM and TAZ/PIPC. Trough concentration of VCM reach a toxic level. Finally, she recovered on day 17.[Image: see text] John Wiley and Sons Inc. 2022-08-03 /pmc/articles/PMC9347319/ /pubmed/35937011 http://dx.doi.org/10.1002/ccr3.6081 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Nakatani, Kaori
Momo, Kenji
Mimura, Takashi
Yoshiizumi, Eri
Sasaki, Tadanori
Acute kidney injury in villous cancer patients treated with vancomycin and tazobactam/piperacillin
title Acute kidney injury in villous cancer patients treated with vancomycin and tazobactam/piperacillin
title_full Acute kidney injury in villous cancer patients treated with vancomycin and tazobactam/piperacillin
title_fullStr Acute kidney injury in villous cancer patients treated with vancomycin and tazobactam/piperacillin
title_full_unstemmed Acute kidney injury in villous cancer patients treated with vancomycin and tazobactam/piperacillin
title_short Acute kidney injury in villous cancer patients treated with vancomycin and tazobactam/piperacillin
title_sort acute kidney injury in villous cancer patients treated with vancomycin and tazobactam/piperacillin
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347319/
https://www.ncbi.nlm.nih.gov/pubmed/35937011
http://dx.doi.org/10.1002/ccr3.6081
work_keys_str_mv AT nakatanikaori acutekidneyinjuryinvillouscancerpatientstreatedwithvancomycinandtazobactampiperacillin
AT momokenji acutekidneyinjuryinvillouscancerpatientstreatedwithvancomycinandtazobactampiperacillin
AT mimuratakashi acutekidneyinjuryinvillouscancerpatientstreatedwithvancomycinandtazobactampiperacillin
AT yoshiizumieri acutekidneyinjuryinvillouscancerpatientstreatedwithvancomycinandtazobactampiperacillin
AT sasakitadanori acutekidneyinjuryinvillouscancerpatientstreatedwithvancomycinandtazobactampiperacillin

Ejemplares similares